Related references
Note: Only part of the references are listed.High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies
Jonathan Tschopp et al.
CLINICAL INFECTIOUS DISEASES (2022)
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective
Frederic Lamoth et al.
CLINICAL INFECTIOUS DISEASES (2022)
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians
Frederic Lamoth
CURRENT OPINION IN INFECTIOUS DISEASES (2022)
Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?
Roya Vahedi-Shahandashti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study
Michele Bartoletti et al.
CLINICAL INFECTIOUS DISEASES (2021)
Invasive mould disease in fatal COVID-19: a systematic review of autopsies
Brittany E. Kula et al.
LANCET MICROBE (2021)
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2021)
Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults
F. Lamoth et al.
CLINICAL INFECTIOUS DISEASES (2021)
Aspergillosis: Emerging risk groups in critically ill patients
Stefan Kluge et al.
MEDICAL MYCOLOGY (2021)
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Johan A Maertens et al.
LANCET (2021)
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta-analysis
Ying Zhang et al.
MYCOSES (2021)
Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections
Gregoire Caudron de Coquereaumont et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa
Romain Guery et al.
ANNALS OF HEMATOLOGY (2021)
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Arnaud Fekkar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Aspergillosis Epidemiology, Diagnosis, and Treatment
Jose Cadena et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2021)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
High -volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum
P. Vergidis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Positive Aspergillus PCR as a marker of azole resistance or sub-therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis
Samihah Moazam et al.
MYCOSES (2020)
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen et al.
DRUGS (2020)
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Paul E. Verweij et al.
INTENSIVE CARE MEDICINE (2020)
Clinical Relevance and Characteristics of Aspergillus calidoustus and Other Aspergillus Species of Section Usti
Emmanouil Glampedakis et al.
JOURNAL OF FUNGI (2020)
CPAnet Registry-An International Chronic Pulmonary Aspergillosis Registry
Christian B. Laursen et al.
JOURNAL OF FUNGI (2020)
Isavuconazole-Animal Data and Clinical Data
Livio Pagano et al.
JOURNAL OF FUNGI (2020)
Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
Yanan Zhao et al.
JOURNAL OF FUNGI (2020)
Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018
Pieter P. A. Lestrade et al.
EMERGING INFECTIOUS DISEASES (2020)
Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside
Marion Aruanno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia
Jason N. Barreto et al.
LEUKEMIA & LYMPHOMA (2019)
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study
Pieter P. Lestrade et al.
CLINICAL INFECTIOUS DISEASES (2019)
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections
Alfred O. Ankrah et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
Koen de Heer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients
Jade Couchepin et al.
MYCOSES (2018)
Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study
D. Neofytos et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study
Sabine Kuster et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Aspergillus PCR in Bronchoalveolar Lavage Fluid for the Diagnosis and Prognosis of Aspergillosis in Patients With Hematological and Non-hematological Conditions
Sebastien Imbert et al.
FRONTIERS IN MICROBIOLOGY (2018)
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study
Alexander F. A. D. Schauwvlieghe et al.
LANCET RESPIRATORY MEDICINE (2018)
Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment
Lore Vanderbeke et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Call for Action: Invasive Fungal Infections Associated With Ibrutinib and Other Small Molecule Kinase Inhibitors Targeting Immune Signaling Pathways
Georgios Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2018)
Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study
Clara Mariette et al.
LEUKEMIA & LYMPHOMA (2017)
Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
Jarrett R. Amsden et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Early diagnosis of invasive mould infections and disease
Frederic Lamoth et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Emergence of Echinocandin Resistance Due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis
Cristina Jimenez-Ortigosa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus
Elena Shekhova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
David W. Denning et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al.
LANCET (2016)
Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections
Werner J. Heinz et al.
MYCOSES (2016)
Aspergillus fumigatus-Related Species in Clinical Practice
Frederic Lamoth
FRONTIERS IN MICROBIOLOGY (2016)
Allergic Bronchopulmonary Aspergillosis
Michael C. Tracy et al.
JOURNAL OF FUNGI (2016)
Combination Antifungal Therapy for Invasive Aspergillosis A Randomized Trial
Kieren A. Marr et al.
ANNALS OF INTERNAL MEDICINE (2015)
Galactomannan and Polymerase Chain Reaction-Based Screening for Invasive Aspergillosis Among High-Risk Hematology Patients: A Diagnostic Meta-analysis
Marios Arvanitis et al.
CLINICAL INFECTIOUS DISEASES (2015)
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
Paul E. Verweij et al.
DRUG RESISTANCE UPDATES (2015)
Voriconazole-associated phototoxic dermatoses and skin cancer
Rakesh K. Goyal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis
Siow Chin Heng et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2015)
Galactomannan detection for invasive aspergillosis in immunocompromised patients
Mariska M. G. Leeflang et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus
J. W. M. van der Linden et al.
EMERGING INFECTIOUS DISEASES (2015)
Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis
Rafael F. Duarte et al.
CLINICAL INFECTIOUS DISEASES (2014)
Nonmolecular Methods for the Diagnosis of Respiratory Fungal Infections
Frederic Lamoth et al.
CLINICS IN LABORATORY MEDICINE (2014)
Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis
Beomsu Shin et al.
JOURNAL OF INFECTION (2014)
A Modern Series of Percutaneous Intracavitary Instillation of Amphotericin B for the Treatment of Severe Hemoptysis From Pulmonary Aspergilloma
Jared N. Kravitz et al.
CHEST (2013)
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Richard J. Hamill
DRUGS (2013)
Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature
Ritesh Agarwal et al.
MYCOSES (2013)
The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis
Yuta Kono et al.
RESPIRATORY MEDICINE (2013)
Aspergillus sp isolated in critically ill patients with extracorporeal membrane oxygenation support
Cecile Aubron et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients
Stijn I. Blot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics-Based Analysis of Adult Patients With Invasive Fungal Infections
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2012)
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan
T. Saito et al.
INFECTION (2012)
Diagnostic Accuracy of PCR Alone Compared to Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis: a Systematic Review
Tomer Avni et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
William J. Steinbach et al.
JOURNAL OF INFECTION (2012)
Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis
Koichi Izumikawa et al.
MEDICAL MYCOLOGY (2012)
Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis
Mingxiang Zou et al.
PLOS ONE (2012)
Comparison of an Aspergillus Real-time Polymerase Chain Reaction Assay with Galactomannan Testing of Bronchoalvelolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis in Lung Transplant Recipients
Me-Linh Luong et al.
CLINICAL INFECTIOUS DISEASES (2011)
Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens
P. Lewis White et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Evaluation of PCR on Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Aspergillosis: A Bivariate Metaanalysis and Systematic Review
Wenkui Sun et al.
PLOS ONE (2011)
Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis A Bivariate Metaanalysis and Systematic Review
Ya-Ling Guo et al.
CHEST (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2010)
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Livio Pagano et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The (1,3)β-D-Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung Transplantation
Barbara D. Alexander et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT
L. Gil et al.
BONE MARROW TRANSPLANTATION (2009)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis
Carlo Mengoli et al.
LANCET INFECTIOUS DISEASES (2009)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies -: A randomized pilot study (Combistrat trial)
Denis Caillot et al.
CANCER (2007)
Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza epidemiologica infezioni fungine nelle emopatie maligne
L. Pagano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis
CD Pfeiffer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus
G Chamilos et al.
DRUG RESISTANCE UPDATES (2005)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients
ML Uffredi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2003)
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
S Perea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis
WR Kirkpatrick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia
D Caillot et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
